Novartis India Share Price in 2012: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2012?

Let's find out!

Novartis India share price in 2012 was ₹671.55 Its price on 1st January 2012 was ₹664.4, and by 31st December 2012 it moved to ₹671.55, giving a positive return of 1.07% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2012 are as follows:

Open	High	Low	Close
₹664.4	₹934.2	₹616.5	₹671.55
1st Jan 2012	Occured in Apr 2012	Occured in Jan 2012	31st Dec 2012

This page will help you understand how Novartis India performed in 2012. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2012

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹656.6	-	↑ ₹680 ↓ ₹616.5
Feb	₹736.2	12.1%	↑ ₹748.9 ↓ ₹646.1
Mar	₹769.75	4.5%	↑ ₹794 ↓ ₹720
Apr	₹816.35	6%	↑ ₹934.2 ↓ ₹749.65
May	₹781.6	-4.3%	↑ ₹830 ↓ ₹700.05
Jun	₹733.4	-6.2%	↑ ₹788.5 ↓ ₹722
Jul	₹658.6	-10.2%	↑ ₹758 ↓ ₹655
Aug	₹691.5	4.9%	↑ ₹709 ↓ ₹659
Sep	₹668.45	-3.4%	↑ ₹740.4 ↓ ₹655
Oct	₹669.6	0.1%	↑ ₹693 ↓ ₹666
Nov	₹676.1	0.9%	↑ ₹693.85 ↓ ₹655
Dec	₹671.55	-0.7%	↑ ₹690 ↓ ₹660.1

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2012?

In 2012, the opening price of Novartis India share was ₹664.40. Today, the price stands at ₹672.25, reflecting a growth of 1.18%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2012 would have become ₹10,118.15 by 2025. This represents a CAGR of 0.09%.

---

You might also like to check: Novartis India Stock Price in 2011 or Novartis India Stock Price in 2013

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.